{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/73042-201#drug","name":"DANYELZA","alternateName":"Naxitamab","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"73042-201"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761171"},{"@type":"PropertyValue","propertyID":"UNII","value":"9K8GNJ2874"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"29a80c6b-8bad-4650-8c7f-f18490c868ec"}],"activeIngredient":"NAXITAMAB","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION","manufacturer":{"@type":"Organization","name":"Y-mAbs Therapeutics, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761171","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29a80c6b-8bad-4650-8c7f-f18490c868ec","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73042-201"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T06:44:50.641Z"}}